{"name":"Hordinsky, Maria K., MD","slug":"hordinsky-maria-k-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Aldara Cream 5%","genericName":"Aldara Cream 5%","slug":"aldara-cream-5","indication":"Actinic keratosis","status":"marketed"}]}],"pipeline":[{"name":"Aldara Cream 5%","genericName":"Aldara Cream 5%","slug":"aldara-cream-5","phase":"marketed","mechanism":"Imiquimod is a toll-like receptor 7 (TLR7) agonist that activates innate immune responses to treat skin lesions.","indications":["Actinic keratosis","Basal cell carcinoma (superficial and nodular)","Genital warts (external)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNRHBEM1h4cUVlWFphVWtab2VWazVpZDJTamE2SGZiaEtadVVmRVFBV1ZyOGF2STY3WEc1NTNqUmt2V2xOb3dWTjVEd3ZNbG4yMlBDd2U2c0dtQk5HRTF1Y1gzdE9GRlYtVjBoY0ZNSVkza3RaZldjdjd2ZFJ4d2k4eVZ3SWZIV3oyME9EVXYwTF9ITXVzZGM2ZGdfYkR3Vm5FTThFaA?oc=5","date":"2025-12-18","type":"trial","source":"HCPLive","summary":"Phase 3 SCALP Study on Clascoterone for Androgenetic Alopecia, With Maria Hordinsky, MD - HCPLive","headline":"Phase 3 SCALP Study on Clascoterone for Androgenetic Alopecia, With Maria Hordinsky, MD","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}